Table 10.
Survival n = 40 | Non-survival n = 80 | P | |
Median age (yr) | 61.50 ± 13.60 | 60.00 ± 14.78 | 0.46 |
(29–84) | (30–89) | ||
Gender | |||
Male | 16 | 39 | 0.18 |
Female | 24 | 41 | 0.18 |
Time interval (mo) | 32.78 ± 27.07 | 32.98 ± 18.58 | 0.49 |
Staging | |||
Stage 1 | 14 | 2 | < 0.01b |
Stage 2 | 19 | 2 | < 0.01b |
Stage 3 | 6 | 41 | 0.04a |
Stage 4 | 1 | 35 | 0.16 |
Treatment regimes2 | |||
Radical | 36 | 16 | < 0.01b |
Palliative | 2 | 36 | 0.08 |
Supportive | 2 | 28 | 0.08 |
1Excluding triple primary cancers nine cases.
Radical treatment includes radical surgery ± radiotherapy ± chemotherapy. Palliative treatment includes palliative surgery±radiotherapy ± chemotherapy.
P<0.05,
P<0.01 vs others.